Arvinas (ARVN) Operating Margin (2017 - 2026)
Arvinas (ARVN) posted quarterly Operating Margin of 408.97% for Q1 2026, down 44679.0% year-over-year from N/an in Q1 2025, and up 47.92% quarter-over-quarter from 785.26% in Q4 2025.
Arvinas (ARVN) Operating Margin (2017 - 2026) Analysis & Trends
Arvinas' Operating Margin history runs 10 years deep, the most recent figure standing at 408.97% for Q1 2026.
- In Q1 2026, Operating Margin fell 44679.0% year-over-year to 408.97%; the TTM figure through Mar 2026 stood at 283.78% (down 26139.0% YoY), while the FY2025 annual figure was 45.13%, up 4986.0% from the prior year.
- Operating Margin for Q1 2026 stood at 408.97%, up from 785.26% in the prior quarter.
- The five-year high for Operating Margin was 383.53% in Q4 2023, with the low at 785.26% in Q4 2025.
- The 5-year median for Operating Margin is 194.67% (2022), against an average of 186.64%.
- The sharpest annual moves came in 2022 and 2025: Operating Margin soared 74896 bps in 2022, then plunged 68695 bps in 2025.
- Arvinas' Operating Margin stood at 200.0% in 2022, then soared by 292 bps to 383.53% in 2023, then sank by 126 bps to 98.31% in 2024, then plunged by 699 bps to 785.26% in 2025, then surged by 48 bps to 408.97% in 2026.
- Business Quant data shows ARVN's Operating Margin at 408.97% in Q1 2026, 785.26% in Q4 2025, and 104.53% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 31.68% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.06% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -105.20% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.75% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 17.93% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.36% |
| 10 | Arvinas | 585.74 Mn | 17.84 Mn | - | 65.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 65.72% |
| Mar 31, 2026 | -408.97% |
| Dec 31, 2025 | -785.26% |
| Sep 30, 2025 | -104.53% |
| Jun 30, 2025 | -319.20% |
| Mar 31, 2025 | 37.82% |
| Dec 31, 2024 | -98.31% |
| Sep 30, 2024 | -58.89% |
| Jun 30, 2024 | -63.40% |
| Mar 31, 2024 | -329.25% |
| Dec 31, 2023 | 383.53% |
| Sep 30, 2023 | -213.58% |
| Jun 30, 2023 | -136.88% |
| Mar 31, 2023 | -269.85% |
| Dec 31, 2022 | -200.00% |
| Sep 30, 2022 | -193.67% |
| Jun 30, 2022 | -194.67% |
| Mar 31, 2022 | -217.74% |
| Dec 31, 2021 | -143.07% |
| Sep 30, 2021 | -508.60% |